Related Experiment Videos

Effect of aspirin on complement in vivo

International Archives of Allergy and Applied Immunology
|January 1, 1980
PubMed

Insights

Aspirin intake temporarily reduced complement activity and C1 inactivator levels in most healthy volunteers. These effects were short-lived, with levels typically normalizing within 30 minutes post-ingestion.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Aspirin is a widely used nonsteroidal anti-inflammatory drug.
  • The complement system is a crucial part of innate immunity.
  • Adverse reactions to aspirin can occur, but their mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the effect of a single 1g aspirin dose on complement consumption in healthy volunteers.
  • To assess changes in complement activity (CH50) and specific complement components (C1, C4, C2).
  • To evaluate the impact of aspirin on C1 inactivator (C1 IA) levels.

Main Methods:

  • Administered 1g of aspirin to 20 healthy volunteers.
  • Measured whole complement activity (CH50) before and after aspirin ingestion.
  • Quantified levels of complement components C1, C4, C2, and C1 inactivator (C1 IA).

Main Results:

  • Complement consumption was observed in 18 out of 20 volunteers.
  • A slight to moderate decrease in CH50, C1, C4, and C2 levels was noted.
  • Reduced C1 IA levels were found in 19 out of 20 volunteers.
  • These changes were transient, with complement titers returning to normal levels within 30 minutes.

Conclusions:

  • Aspirin ingestion transiently activates complement consumption and reduces C1 IA levels in healthy individuals.
  • The observed effects are short-lived, suggesting a limited role in chronic aspirin-related adverse events.
  • Further research is warranted to explore the precise role of complement in aspirin's pharmacological actions and potential adverse reactions.

Related Concept Videos